Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Rothman

Showing results (101-110 of 159) with videos related to

Pageof 16
Sort By:
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and biological evaluation of 14-alkoxymorphinans. 17. Highly delta opioid receptor selective 14-alkoxy-substituted indolo- and benzofuromorphinansJohannes Schütz, Christina M Dersch, Robert Horel, et al.
Journal of Natural Products|February 23, 2011
Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin AAnthony Lozama, Christopher W Cunningham, Michael J Caspers, et al.
European Journal of Medicinal Chemistry|November 22, 2012
Probes for narcotic receptor mediated phenomena. 46. N-substituted-2,3,4,9,10,10a-hexahydro-1H-1,4a-(epiminoethano)phenanthren-6- and 8-ols - carbocyclic relatives of f-oxide-bridged phenylmorphansFuying Li, Jason A Deck, Christina M Dersch, et al.
Synapse (New York, N.Y.)|September 30, 2003
High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrainRichard B Rothman, Subramaniam Jayanthi, Xiaoying Wang, et al.
European Journal of Medicinal Chemistry|February 21, 2012
Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activityMalliga R Iyer, Yong Sok Lee, Jeffrey R Deschamps, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 7, 2009
Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinilDorota Zolkowska, Raka Jain, Richard B Rothman, et al.
Experimental and Clinical Psychopharmacology|May 7, 2014
Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeysMatthew L Banks, Clayton T Bauer, Bruce E Blough, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Synthesis, opioid receptor binding, and functional activity of 5'-substituted 17-cyclopropylmethylpyrido[2',3':6,7]morphinansSubramaniam Ananthan, Hollis S Kezar, Surendra K Saini, et al.
Bioorganic & Medicinal Chemistry|December 17, 2009
Probes for narcotic receptor mediated phenomena. 40. N-substituted cis-4a-ethyl-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-8-olsMalliga R Iyer, Yong Sok Lee, Jeffrey R Deschamps, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ringWayne W Harding, Matthew Schmidt, Kevin Tidgewell, et al.
Pageof 16

Showing results (101-110 of 159) with videos related to

Sort By:
Pageof 16
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and biological evaluation of 14-alkoxymorphinans. 17. Highly delta opioid receptor selective 14-alkoxy-substituted indolo- and benzofuromorphinansJohannes Schütz, Christina M Dersch, Robert Horel, et al.
Journal of Natural Products|February 23, 2011
Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin AAnthony Lozama, Christopher W Cunningham, Michael J Caspers, et al.
European Journal of Medicinal Chemistry|November 22, 2012
Probes for narcotic receptor mediated phenomena. 46. N-substituted-2,3,4,9,10,10a-hexahydro-1H-1,4a-(epiminoethano)phenanthren-6- and 8-ols - carbocyclic relatives of f-oxide-bridged phenylmorphansFuying Li, Jason A Deck, Christina M Dersch, et al.
Synapse (New York, N.Y.)|September 30, 2003
High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrainRichard B Rothman, Subramaniam Jayanthi, Xiaoying Wang, et al.
European Journal of Medicinal Chemistry|February 21, 2012
Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activityMalliga R Iyer, Yong Sok Lee, Jeffrey R Deschamps, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 7, 2009
Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinilDorota Zolkowska, Raka Jain, Richard B Rothman, et al.
Experimental and Clinical Psychopharmacology|May 7, 2014
Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeysMatthew L Banks, Clayton T Bauer, Bruce E Blough, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Synthesis, opioid receptor binding, and functional activity of 5'-substituted 17-cyclopropylmethylpyrido[2',3':6,7]morphinansSubramaniam Ananthan, Hollis S Kezar, Surendra K Saini, et al.
Bioorganic & Medicinal Chemistry|December 17, 2009
Probes for narcotic receptor mediated phenomena. 40. N-substituted cis-4a-ethyl-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-8-olsMalliga R Iyer, Yong Sok Lee, Jeffrey R Deschamps, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ringWayne W Harding, Matthew Schmidt, Kevin Tidgewell, et al.
Pageof 16